For example, NHE is involved in breast cancer and melanoma invasion and metastasis (Stüwe et al., 2007; Amith and Fliegel, 2013; Vahle et al., 2014) indicating that NHE1 may be a suitable target for anticancer therapy (Stock et al., 2012). This evidence concerns the gene SLC9A1 and breast carcinoma.